Today, we shared preclinical data evaluating CLN-978, our CD19xCD3 bispecific T cell engager. These data will be presented at #ACR24 on Saturday, November 16, between 10:30 a.m. and 12:30 p.m. ET. Learn more: https://bit.ly/4fxb5mL